Enteric infection and dysfunction—A new target for PLOS Neglected Tropical Diseases

PLoS Neglected Tropical Diseases

Volumn 12, Issue 12, 2018, Pages

  Arndt, Michael B ^a,b   Walson, Judd L ^b,c,d  

^a PATH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d The Childhood Acute Illness and Nutrition Network (CHAIN)   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALPHA1 GLYCOPROTEIN; C REACTIVE PROTEIN; CALGRANULIN; FERRITIN; IMMUNOGLOBULIN G; MYELOPEROXIDASE; NEOPTERIN; RIFAXIMIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACUTE DIARRHEA; BRAIN DEVELOPMENT; CARDIOVASCULAR RISK; CHOLERA; COGNITIVE DEVELOPMENT; DISEASE SEVERITY; EDITORIAL; ENTERITIS; GIARDIASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INTESTINE INFECTION; MORBIDITY; MORTALITY RISK; NEGLECTED DISEASE; NONHUMAN; PATHOGEN LOAD; SCHISTOSOMIASIS; CLASSIFICATION; ENTEROPATHY; TROPICAL MEDICINE;

HUMANS; INTESTINAL DISEASES; NEGLECTED DISEASES; TROPICAL MEDICINE;

EID: 85059243412     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0006906     Document Type: Editorial

References (43)

1. Bartelt LA, Lima AA, Kosek M, Peñataro Yori P, Lee G, Guerrant RL, "Barriers" to child development and human potential: the case for including the "neglected enteric protozoa" (NEP) and other enteropathy-associated pathogens in the NTDs. PLoS Negl Trop Dis. 2013;7(4):e2125. doi: 10.1371/journal.pntd.0002125 pmid: 23593514
2. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209–22. doi: 10.1016/S0140-6736(13)60844-2 pmid: 23680352
3. Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016;388(10051):1291–301. doi: 10.1016/S0140-6736(16)31529-X pmid: 27673470
4. Kosek MN, Investigators M-EN, Causal Pathways from Enteropathogens to Environmental Enteropathy: Findings from the MAL-ED Birth Cohort Study. EBioMedicine. 2017;18:109–17. doi: 10.1016/j.ebiom.2017.02.024 pmid: 28396264
5. Amour C, Gratz J, Mduma E, Svensen E, Rogawski ET, McGrath M, et al. Epidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings: Results From the MAL-ED Study. Clin Infect Dis. 2016
6. Nataro JP, Guerrant RL, Chronic consequences on human health induced by microbial pathogens: Growth faltering among children in developing countries. Vaccine. 2017;35(49 Pt A):6807–12
7. Lee GO, Olortegui MP, Salas MS, Yori PP, Trigoso DR, Kosek P, et al. Environmental enteropathy is associated with cardiometabolic risk factors in Peruvian children. J Dev Orig Health Dis. 2017;8(3):337–48. doi: 10.1017/S2040174417000071 pmid: 28264759
8. Guerrant RL, DeBoer MD, Moore SR, The impoverished gut—a triple burden of diarrhoea, stunting and chronic disease. Nature Reviews. 2013
9. Keusch GT, Denno DM, Black RE, Duggan C, Guerrant RL, Lavery JV, et al. Environmental Enteric Dysfunction: Pathogenesis, Diagnosis, and Clinical Consequences. Clinical Infectious Diseases. 2014;59(suppl 4):S207–S12
10. Korpe PS, Petri WA, Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med. 2012;18(6):328–36. doi: 10.1016/j.molmed.2012.04.007 pmid: 22633998
11. Prendergast A, Kelly P, Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hyg. 2012;86(5):756–63. doi: 10.4269/ajtmh.2012.11-0743 pmid: 22556071
12. Jones AD, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya MN, et al. Acute illness is associated with suppression of the growth hormone axis in Zimbabwean infants. Am J Trop Med Hyg. 2015;92(2):463–70. doi: 10.4269/ajtmh.14-0448 pmid: 25535308
13. Prendergast A, S, Rukobo S, Rukobo r, Chasekwa B, Mutasa K, et al. Stunting is characterized by chronic inflammation in Zimbabwean infants. PLoS ONE. 2014;9(2):e86928. doi: 10.1371/journal.pone.0086928 pmid: 24558364
14. Fazeli P, Klibanski A, Determinants of GH resistance in malnutrition. The Journal of Endocrinology. 2014;220(3):R57–65. doi: 10.1530/JOE-13-0477 pmid: 24363451
15. Fazeli P, Misra M, Goldstein M, Miller K, Klibanski A, Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. The Journal of Clinical Endocrinology and Metabolism. 2010;95(1):369–74. doi: 10.1210/jc.2009-1730 pmid: 19926712
16. DeBoer MD, Scharf RJ, Leite AM, Férrer A, Havt A, Pinkerton R, et al. Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutrition. Nutrition. 2017;33:248–53. doi: 10.1016/j.nut.2016.06.013 pmid: 27712965
17. Brown EM, Wlodarska M, Willing BP, Vonaesch P, Han J, Reynolds LA, et al. Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat Commun. 2015;6:7806. doi: 10.1038/ncomms8806 pmid: 26241678
18. Schwarzer M, Makki K, Storelli G, Machuca-Gayet I, Srutkova D, Hermanova P, et al. Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science. 2016;351(6275):854–7. doi: 10.1126/science.aad8588 pmid: 26912894
19. Denno DM, Tarr PI, Nataro JP, Environmental Enteric Dysfunction: A Case Definition for Intervention Trials. Am J Trop Med Hyg. 2017
20. McGrath CJ, Arndt MB, Walson JL, Biomarkers to Stratify Risk Groups among Children with Malnutrition in Resource-Limited Settings and to Monitor Response to Intervention. Horm Res Paediatr. 2017
21. Peterson KM, Buss J, Easley R, Yang Z, Korpe PS, Niu F, et al. REG1B as a predictor of childhood stunting in Bangladesh and Peru. Am J Clin Nutr. 2013;97(5):1129–33. doi: 10.3945/ajcn.112.048306 pmid: 23553156
22. Kosek M, Haque R, Lima A, Babji S, Shrestha S, Qureshi S, et al. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg. 2013;88(2):390–6. doi: 10.4269/ajtmh.2012.12-0549 pmid: 23185075
23. Guerrant RL, Leite AM, Pinkerton R, Medeiros PH, Cavalcante PA, DeBoer M, et al. Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil. PLoS ONE. 2016;11(9):e0158772. doi: 10.1371/journal.pone.0158772 pmid: 27690129
24. Arndt MB, Richardson BA, Ahmed T, Mahfuz M, Haque R, John-Stewart GC, et al. Fecal Markers of Environmental Enteropathy and Subsequent Growth in Bangladeshi Children. Am J Trop Med Hyg. 2016;95(3):694–701. doi: 10.4269/ajtmh.16-0098 pmid: 27352872
25. Denno DM, VanBuskirk K, Nelson ZC, Musser CA, Hay Burgess DC, Tarr PI, Use of the Lactulose to Mannitol Ratio to Evaluate Childhood Environmental Enteric Dysfunction: A Systematic Review. Clinical Infectious Diseases. 2014;59(suppl 4):S213–S9
26. Faubion W, Camilleri M, Murray J, Kelly P, Amadi B, Kosek M, et al. Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene. BMJ Global Health. 2016;1(1):e000066. doi: 10.1136/bmjgh-2016-000066 pmid: 28588929
27. Kosek MN, Mduma E, Kosek PS, Lee GO, Svensen E, Pan WK, et al. Plasma Tryptophan and the Kynurenine-Tryptophan Ratio are Associated with the Acquisition of Statural Growth Deficits and Oral Vaccine Underperformance in Populations with Environmental Enteropathy. Am J Trop Med Hyg. 2016;95(4):928–37. doi: 10.4269/ajtmh.16-0037 pmid: 27503512
28. Naylor C, Lu M, Haque R, Mondal D, Buonomo E, Nayak U, et al. Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh. EBioMedicine. 2015;2(11):1759–66. doi: 10.1016/j.ebiom.2015.09.036 pmid: 26870801
29. Prendergast A, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya M, et al. Stunting Is Characterized by Chronic Inflammation in Zimbabwean Infants. PLoS ONE. 2014;9(2):e86928. doi: 10.1371/journal.pone.0086928 pmid: 24558364
30. Harper KM, Mutasa M, Prendergast AJ, Humphrey J, Manges AR, Environmental enteric dysfunction pathways and child stunting: A systematic review. PLoS Negl Trop Dis. 2018;12(1):e0006205. doi: 10.1371/journal.pntd.0006205 pmid: 29351288
31. Campbell RK, Schulze KJ, Shaikh S, Raqib R, Wu LSF, Ali H, et al. Environmental enteric dysfunction and systemic inflammation predict reduced weight but not length gain in rural Bangladeshi children. Br J Nutr. 2018;119(4):407–14. doi: 10.1017/S0007114517003683 pmid: 29498344
32. Campbell RK, Schulze KJ, Shaikh S, Mehra S, Ali H, Wu L, et al. Biomarkers of Environmental Enteric Dysfunction Among Children in Rural Bangladesh. J Pediatr Gastroenterol Nutr. 2017;65(1):40–6. doi: 10.1097/MPG.0000000000001557 pmid: 28644348
33. Galpin L, Manary M, Fleming K, Ou C-N, Ashorn P, Shulman R, Effect of Lactobacillus GG on intestinal integrity in Malawian children at risk of tropical enteropathy. The American journal of clinical nutrition. 2005;82(5):1040–5. doi: 10.1093/ajcn/82.5.1040 pmid: 16280436
34. Trehan I, Shulman R, Ou C-N, Maleta K, Manary M, A Randomized, Double-Blind, Placebo-Controlled Trial of Rifaximin, a Nonabsorbable Antibiotic, in the Treatment of Tropical Enteropathy. The American Journal of Gastroenterology. 2009;104(9):2326–33. doi: 10.1038/ajg.2009.270 pmid: 19491826
35. Wang AZ, Shulman RJ, Crocker AH, Thakwalakwa C, Maleta KM, Devaraj S, et al. A Combined Intervention of Zinc, Multiple Micronutrients, and Albendazole Does Not Ameliorate Environmental Enteric Dysfunction or Stunting in Rural Malawian Children in a Double-Blind Randomized Controlled Trial. J Nutr. 2016
36. Ryan KN, Stephenson KB, Trehan I, Shulman RJ, Thakwalakwa C, Murray E, et al. Zinc or Albendazole Attenuates the Progression of Environmental Enteropathy: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology. 2014
37. van der Merwe LF, Moore SE, Fulford AJ, Halliday KE, Drammeh S, Young S, et al. Long-chain PUFA supplementation in rural African infants: a randomized controlled trial of effects on gut integrity, growth, and cognitive development. Am J Clin Nutr. 2013;97(1):45–57. doi: 10.3945/ajcn.112.042267 pmid: 23221579
38. Jones KD, Hünten-Kirsch B, Laving AM, Munyi CW, Ngari M, Mikusa J, et al. Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial. BMC Med. 2014;12:133. doi: 10.1186/s12916-014-0133-2 pmid: 25189855
39. Cheng WD, Wold KJ, Benzoni NS, Thakwalakwa C, Maleta KM, Manary MJ, et al. Lactoferrin and lysozyme to reduce environmental enteric dysfunction and stunting in Malawian children: study protocol for a randomized controlled trial. Trials. 2017;18(1):523. doi: 10.1186/s13063-017-2278-8 pmid: 29110675
40. Null C, Stewart CP, Pickering AJ, Dentz HN, Arnold BF, Arnold CD, et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Kenya: a cluster-randomised controlled trial. Lancet Glob Health. 2018;6(3):e316–e29. doi: 10.1016/S2214-109X(18)30005-6 pmid: 29396219
41. Luby SP, Rahman M, Arnold BF, Unicomb L, Ashraf S, Winch PJ, et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Bangladesh: a cluster randomised controlled trial. Lancet Glob Health. 2018;6(3):e302–e15. doi: 10.1016/S2214-109X(17)30490-4 pmid: 29396217
42. N Medgyesi D, Sewell D, Senesac R, Cumming O, Mumma J, Baker K, The Landscape of Enteric Pathogen Exposure of Young Children in Public Domains of Low-Income, Urban Kenya: The Influence of Exposure Pathway and Spatial Range of Play on Multi-Pathogen Exposure Risks2018
43. Baker KK, Senesac R, Sewell D, Sen Gupta A, Cumming O, Mumma J, Fecal Fingerprints of Enteric Pathogen Contamination in Public Environments of Kisumu, Kenya, Associated with Human Sanitation Conditions and Domestic Animals. Environ Sci Technol. 2018;52(18):10263–74. doi: 10.1021/acs.est.8b01528 pmid: 30106283